Our Board Members

Cartherics has a strong leadership team, experienced in immunology, stem cell biology, commercialisation and product development in immune therapies, with deep connections to academia.

Mr Bob Moses BA, MBA
Chairman

Founder, Executive, Chairman, CEO of multiple life science companies over the past 40 years. Bob Moses has executive experience with Eli Lilly, ICI Australia, CSL Limited, Freehills, Amrad, Meditech, Daratech, Australian Stem Cell Centre, TGR Biosciences, CRC for Polymers.

Professor Alan Trounson AO MSc, PhD, LLD, FRCOG, FATSE, FAHMS, FRANZCOG
CEO & Executive Director

Stem cell biologist, IVF pioneer & former President of the California Institute for Regenerative Medicine. Alan Trounson is Emeritus Professor Monash University and Distinguished Scientist, Hudson Institute for Medical Research, Clayton, Victoria, Australia.

Dr Colin Lee MBBS, FRCOG, MMED, O&G
Non-Executive Director

Gynaecologist and fertility specialist. Dr. Colin Lee is the founder of TMC Life Sciences Bhd, an IVF company he publicly listed in 2005. He is also the Founder and Medical Director of Alpha International Fertility Centre, Kuala Lumpur.

Professor Bryan R. G. Williams PhD, BSc (Hons), Hon FRSNZ, FAA
Non-Executive Director

Professor Bryan R.G. Williams is an internationally recognised cancer researcher with considerable Board experience, including Pacific Edge Pty Ltd, EngenelC Pty Ltd, MEI Pharma, Cancer Trials Australia, Hope Funds for Cancer Research and BioGrid Australia Ltd.

He is a professor at Monash University and Hudson Institute of Medical Research. Fellow of the Australian Academy of Science and Fellow of the American Academy of Microbiology.

Ms Geraldine (Gerry) Farrell BSc, LLB, LLM, GAICD
Non-Executive Director

Gerry Farrell is an operations executive, general counsel, company secretary and IP & commercial lawyer, with more than 20 years’ experience in the Australian biotechnology industry, having worked with several listed and unlisted companies.

Currently General Counsel, Corporate at Orica Limited, she has held previous positions at Cann Group Limited (medicinal cannabis), Nexvet (now part of Zoetis), leading corporate and IP law firms, and former council member of Swinburne University of Technology.

Mr Henry Kho BCom (Hons)
Non-Executive Director

Co-Founder and retired Executive Director of Perdana Petroleum Berhad listed on Kuala Lumpur Stock Exchange, Malaysia. Henry Kho is experienced in business development, corporate exercise, capital raising, merger and acquisitions.

Heather Hawkins
Board Advisor

Heather Hawkins is a woman of two lives – from an everyday mother of two who battled Ovarian Cancer at age 41 with an unknown future, to an international adventurer, stepping into the world of extreme marathons in some of the world’s most inhospitable locations. Heather’s is not just another remarkable and inspiring story, but one that will take you on a personal journey around the world, into the ice and winds of the North Pole and Antarctica, to the sands and scorching heat of the Sahara and Outback Australia and across the majestic roof tops of the Himalayas, Chile and Tanzania.

Mr Phillip Hains
Company Co-Secretary

Founder of specialist accounting firm The CFO Solution, Phillip Hains has worked as a service provider to the technology sector for over 25 years. He is currently CFO & Company Secretary to a number of listed and unlisted health technology companies.

Key Executives

Professor Alan Trounson AO MSc, PhD, LLD, FRCOG, FATSE, FAHMS, FRANZCOG
CEO & Executive Director

Stem cell biologist, IVF pioneer & former President of the California Institute for Regenerative Medicine. Alan Trounson is Emeritus Professor Monash University and Distinguished Scientist, Hudson Institute for Medical Research, Clayton, Victoria, Australia.

Dr Richard Boyd BSc (Hons), PhD
Chief Scientific Officer

Professor of Immunology at Monash University, Dr Richard Boyd is an expert in the nature and function of the thymus microenvironment for forming T cells from blood stem cells and pioneer of clinical trials to boost the T cell-based immune system in cancer patients through rejuvenation of the thymus.

Dr Ian Nisbet PhD
Chief Operating Officer

Dr Ian Nisbet is the founder, Executive, Chairman or CEO of multiple life sciences companies, including several in Oncology. He brings over 25 years of direct biotech, strategic and operational experience to the team.

Telma Mantas
Director, IP and Licensing

Telma is the Director of IP and Licensing for Cartherics. She is responsible for managing IP, licensing-in opportunities, and competitive intelligence activities. She has more than 15 years of experience in IP and innovation, having worked as an Intellectual Property Manager, Patent Examiner and Business Consultant in various organisations worldwide.